Cargando…
Targeting Protein Kinase G to Treat Cardiac Proteotoxicity
Impaired or insufficient protein kinase G (PKG) signaling and protein quality control (PQC) are hallmarks of most forms of cardiac disease, including heart failure. Their dysregulation has been shown to contribute to and exacerbate cardiac hypertrophy and remodeling, reduced cell survival and diseas...
Autores principales: | Oeing, Christian U., Mishra, Sumita, Dunkerly-Eyring, Brittany L., Ranek, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399205/ https://www.ncbi.nlm.nih.gov/pubmed/32848832 http://dx.doi.org/10.3389/fphys.2020.00858 |
Ejemplares similares
-
Phosphorylation Modifications Regulating Cardiac Protein Quality Control Mechanisms
por: Mishra, Sumita, et al.
Publicado: (2020) -
Editorial: Targeting Cardiac Proteotoxicity
por: Ranek, Mark J., et al.
Publicado: (2021) -
Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1/2 but not Akt
por: Dunkerly-Eyring, Brittany L, et al.
Publicado: (2022) -
CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury
por: Ranek, Mark J., et al.
Publicado: (2020) -
Editorial: New Drug Targets for Proteotoxicity in Cardiometabolic Diseases
por: Ren, Jun, et al.
Publicado: (2021)